R

Rezolute
D

RZLT

4.99500
USD
0.21
(4.28%)
Market Closed
Volume
17,704
EPS
-1
Div Yield
-
P/E
-4
Market Cap
289,425,615
News

Title: Rezolute

Sector: Healthcare
Industry: Biotechnology
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.